Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering
Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company“) is pleased to announce that it has closed the third tranche (the “Third Tranche“) of its previously announced non-brokered private placement […]




